Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipelineGilead is making headlines with its planned acquisition of Tubulis GmbH, a Germany-based company, for a maximum of five billion dollars. Th...
Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billionGilead will pay $115 per share in cash at the deal's closing, which is at a premium of 79% to the stock's last close. Kite Pharma, a unit ?...
US stock market crashes today: Why Dow, SP 500, Nasdaq down again today? Wall Street moving like Trump tariffs — no clue whatsoeverUS stock market crashes today. The Dow Jones fell 261 points to 49,364. The S&P 500 dropped 0.29% to 6,889. The Nasdaq slid 0.44% to 22,786...